Excel downloads of Key Tables
Key performance indicators
|Employees injury frequency rate
||(No. of accidents per million of worked hours)
|Contractors injury frequency rate
|Net sales from operations(a)
|Adjusted operating profit
|Adjusted net profit
|Sales of petrochemical products
|Average plant utilization rate
|Employees at year end
|Direct GHG emissions
|NMVOC (Non-Methan Volatile Organic Compound) emissions
|SOx emissions (sulphur oxide)
||(ktonnes SO2 eq)
|NOx emissions (nitrogen oxide)
||(ktonnes NO2 eq)
Performance of the year
- In 2012 the employees and contractors injury frequency rates continued to follow the positive trends of previous years (down 48.3% and 63.9%, respectively).
- In 2012 emissions of greenhouse gases, NOX and SO2 decreased due to lower sales volumes and to energy saving interventions performed in the year. An increase in NMVOC emissions is due mainly to the Dunkirk site because the NMVOC recovery plant was unavailable for emissions from the polyethylene silos.
- In 2012 the sector reported a significant increase in adjusted net loss (€395 million, down €189 million) from 2011, due to a weak trend in demand for commodities reflecting the economic downturn and a fall in unit margins.
- Sales of petrochemical products were 3,953 ktonnes, down 87 ktonnes, or 2.1% from 2011, due to declining consumption.
- Petrochemical production volumes were 6,090 ktonnes, decreasing by 155 ktonnes, down 2.48%, due a steep decline in demand for petrochemical products in all businesses, in particular the steepest decline was reported in polyethylene.
- In 2012 overall expenditure in R&D amounted to approximately €38 million in line with the previous year. A total of new 18 patent applications were filed, including one in collaboration with Exploration and Production division.
Expansion on international markets
- In the field of internationalization strategy, in October 2012, Versalis signed 2 joint venture agreements with major chemical operators in South Korea and Malaysia to build and operate facilities for the production of elastomers incorporating Versalis proprietary technologies and know-how. These initiatives are in line with Eni’s strategy of international expansion in Asian markets with interesting growth prospects, where Versalis has a leading position (elastomers).
- In January 2013, Versalis and Yulex, an agricultural-based biomaterials company, signed a strategic partnership to manufacture guayule-based bio-rubber materials in a production complex in Southern Europe. The partnership will cover the entire manufacturing chain from crop science to bio-rubber extraction to the construction of a biomass power station. Versalis will manufacture materials for consumer and medical specialty markets with hypoallergenic qualities that are expected to generate higher margins.
The partnership will leverage Yulex’s core competencies including crop science and bio-rubber extraction technologies, to boost Versalis’ bio-based portfolio. The investment will include an ambitious research project to develop technologies targeting the tire industry.
With its market leading position in the elastomer industry Versalis plans to expand its leading-edge technologies in the synthetic rubber business by including guayule rubber as a supplementary business opportunity and an increased commercial offering.
In June 2012, a Memorandum of Understanding has been signed with Genomatica and Novamont to establish a technological joint venture in Italy governing a four-year research project aimed at developing a new technology for the production of butadiene from renewable feedstocks. This joint venture will also hold exclusive right for the industrial application of the research results, including licensing it to third parties.